‘Cutting the cable’ between CD8+ T and T regulatory cells enhances checkpoint immunotherapy
Discovery by UC Irvine-led team may offer new strategy for improving melanoma treatment
June 10, 2024
KEYWORD
cancer
UC Irvine study reveals circadian clock can be leveraged to enhance cancer immunotherapy
Optimizing individual time-of-day delivery offers new avenues for prevention and treatment
May 28, 2024
UC Irvine-led research team discovers role of key enzymes that drive cancer mutations
APOBEC3A and APOBEC3B offer potential new targets for intervention strategies
March 18, 2024
UC Irvine researchers awarded grants by the Chan Zuckerberg Initiative
Funding supports research into advanced biological tissue imaging technologies
February 21, 2024
UC Irvine-led study links biomarkers and chemotherapy-related gastrointestinal symptoms
Predictors may offer new targets for pre-treatment therapeutic approaches
January 24, 2024
UC Irvine professor to help design the most powerful laser in the world
The NSF-funded effort would help the U.S. to reclaim lead in laser technology
November 07, 2023
UCI awarded $2.4 million grant to study potential treatment for cancer-related cognitive impairment
Study to evaluate potential treatment approach for ‘chemobrain’
September 19, 2023
UC Irvine-led study links low-dose radiation to higher cancer risk
Caution warranted given increased public exposure in recent decades
August 16, 2023
Anai Campos Contreras named 2023 Pew Latin American Fellow in the Biomedical Sciences
The Pew Charitable Trusts has named Anai Campos Contreras, incoming UC Irvine postdoctoral fellow in pharmacy and pharmaceutical sciences, a 2023 Pew Latin American Fellow in the Biomedical Sciences. Campos received a Ph.D. in biomedical sciences in 2022 from the National Autonomous University of Mexico. Later this summer, she will join the laboratory of Thomas Martinez, […]
June 13, 2023